Dr Thomas Hohman

Biography

Thomas Hohman, PhD was formerly Head of Retina Discovery and Vice President of Retina Translation Medicine at Allergan, where he was responsible for discovering and advancing new treatments for retinal diseases.  Prior to retiring, his efforts at Allergan focused on identifying biomarkers and methods quantifying retina functional changes that predict disease progression. These efforts formed the basis for clinical interventional studies of novel treatments for exudative age related macular degeneration and geographic atrophy. Prior to his tenure at Allergan, Dr. Hohman held leadership positions at Alcon Research as VP of Retinal Research and Development, and at Novartis as Disease Area Section Head for Ophthalmology Clinical Research and Development.

Research Interest

  Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology Pharmaceutical Technology Pharmaceutical Manufacturing Pharmaceutical Engineering Drug Delivery Technologies Medical Devices Drug Regulatory Affairs Pharmaceutical Management